Resveratrol for cancer therapy: Challenges and future perspectives

Resveratrol (3,4’,5-trihydroxy-trans-stilbene) has been expected to ameliorate cancer and foster breakthroughs in cancer therapy. Despite thousands of preclinical studies on the anticancer activity of resveratrol, little progress has been made in translational research and clinical trials. Most stud...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer letters Jg. 515; S. 63 - 72
Hauptverfasser:	Ren, Boxu, Kwah, Marabeth Xin-Yi, Liu, Cuiliu, Ma, Zhaowu, Shanmugam, Muthu K., Ding, Lingwen, Xiang, Xiaoqiang, Ho, Paul Chi-Lui, Wang, Lingzhi, Ong, Pei Shi, Goh, Boon Cher
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Ireland Elsevier B.V 01.09.2021 Elsevier Limited
Schlagworte:	Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Antitumor activity Antitumor agents Bioavailability Biomarkers Cancer Cancer therapies Cancer treatment Chemotherapy Clinical trials Colorectal cancer Cytotoxicity Functional foods & nutraceuticals Humans Insulin Insulin-like growth factors Multiple myeloma Neoplasms - drug therapy Pharmacodynamics Pharmacokinetics Plasma Proteins Resveratrol Resveratrol - pharmacology Resveratrol - therapeutic use Signal transduction Signal Transduction - drug effects Skin Toxicity trans-Stilbene Tumor necrosis factor-TNF Tumorigenesis Cmax PGE2 Pharmacodynamics AST Cancer treatment Toxicity VEGF ALT IGF-1 Vd RASSF-1a MCP1 IGFBP-3 MPX TNF-α Resveratrol IC50 Tmax AMPK Pharmacokinetics Wnt
ISSN:	0304-3835, 1872-7980, 1872-7980
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!